Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 19;7(1):53-60.
doi: 10.3233/BLC-200397. eCollection 2021.

Evaluating Patient-Defined Priorities for Female Patients with Bladder Cancer

Affiliations

Evaluating Patient-Defined Priorities for Female Patients with Bladder Cancer

Amanda X Vo et al. Bladder Cancer. .

Abstract

Background: Although bladder cancer is much more common in men than in women, female patients with bladder cancer present with more locally advanced tumors and have worse disease-specific outcomes than male patients, even after controlling for biological differences. There is a paucity of research regarding the optimal approach to caring for female patients with bladder cancer in ways that maximize patient satisfaction, preferences, and values.

Objective: We sought to explore patient-defined priorities and areas in need of improvement for female patients with bladder cancer from the patient perspective.

Methods: We conducted focus group sessions and semi-structured interviews of women treated for bladder cancer to identify patient priorities and concerns until reaching topic saturation. Transcripts were analyzed thematically.

Results: Eight patients with muscle-invasive bladder cancer and six patients with non-muscle-invasive bladder cancer participated in two focus groups and seven interviews total. Three themes emerged as significantly affecting the care experience: physical impacts, mental health and emotional wellbeing, and the patient-provider interaction. Each theme included patient-defined specific recommendations on approaches to optimizing the care experience for women with bladder cancer.

Conclusions: Although most participants were satisfied with the quality of care they received, they identified several opportunities for improvement. These concerns centered around enhancing support for patients' physical and mental needs and strengthening the patient-provider interaction. Efforts to address these needs and reduce gender disparate outcomes via quality improvement initiatives are ongoing.

Keywords: Urinary bladder neoplasms; patient advocacy; qualitative research; quality improvement.

PubMed Disclaimer

Conflict of interest statement

Amanda Vo, Mary Kate Keeter, and Emily Tuchman do not have conflicts of interest related to this work to declare. Alicia Morgans has the following honoraria for advisory board activities to report: Janssen, Sanofi, Astellas, AstraZeneca, Bayer, Dendreon, Myovant, Advanced Accelerator Applications, and Clovis. In addition, Alicia Morgans has the following research collaborations to report: Bayer, Seattle Genetics, Astellas, Sanofi, Dendreon. Joshua Meeks does consulting work for Merck, AstraZeneca, Ferring, Cold Genesys, Janssen, Nucleix, and Foundation Medicine. He is funded for research by Abbvie, Tesaro, Epizyme, Prostate Cancer Foundation, Hope Foundation, VHA, NIH, and DoD. He has received education funding for lectures from AUA, OncLive, University North Carolina, and ASCO. Lastly, Dr. Meeks has clinical trials with SWOG, Genentech, Merck, and AstraZeneca.

Similar articles

References

    1. American Cancer Society. Cancer Facts & Figures 2019. Atlanta, GA: American Cancer Society, 2019.
    1. Dobruch J, Daneshmand S, Fisch M, et al. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. European Urology. 2016;69:300–10. - PubMed
    1. Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115:68. - PubMed
    1. Pozzar RA, Berry DL. Gender Differences in Bladder Cancer Treatment Decision Making. Oncology Nursing Forum. 2017;44:204. - PubMed
    1. Barbosa CD, Balp MM, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Preference and Adherence. 2012;6:39. - PMC - PubMed

LinkOut - more resources